Gene: PDLIM5
Official Full Name: PDZ and LIM domain 5provided by HGNC
Gene Summary: This gene encodes a member of a family of proteins that possess a 100-amino acid PDZ domain at the N terminus and one to three LIM domains at the C-terminus. This family member functions as a scaffold protein that tethers protein kinases to the Z-disk in striated muscles. It is thought to function in cardiomyocyte expansion and in restraining postsynaptic growth of excitatory synapses. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06124 | PDLIM5 Knockout cell line (HeLa) | Human | PDLIM5 | 1:3~1:6 | Negative | Online Inquiry |
KO06125 | PDLIM5 Knockout cell line (HCT 116) | Human | PDLIM5 | 1:2~1:4 | Negative | Online Inquiry |
KO06126 | PDLIM5 Knockout cell line (HEK293) | Human | PDLIM5 | 1:3~1:6 | Negative | Online Inquiry |
KO06127 | PDLIM5 Knockout cell line (A549) | Human | PDLIM5 | 1:3~1:4 | Negative | Online Inquiry |
PDLIM5 Gene Knockout Cell Lines represent a pioneering tool for researchers investigating cellular processes and pathways governed by the PDLIM5 gene, which encodes a member of the PDZ-LIM protein family known to play critical roles in cell signaling and cytoskeletal organization. These engineered cell lines have been specifically designed to enable the comprehensive study of PDLIM5's function in various biological contexts, particularly its influence on cell proliferation, differentiation, and response to external stimuli.
The primary mechanism of the PDLIM5 Gene Knockout Cell Lines is based on CRISPR-Cas9 gene-editing technology, which facilitates precise disruption of the PDLIM5 gene. This knockout approach allows scientists to observe the resulting phenotypic changes, elucidate the gene's role in cellular processes, and investigate its potential involvement in diseases such as cancer or cardiovascular disorders. Furthermore, these cell lines serve as invaluable platforms for drug discovery and the evaluation of therapeutic strategies aimed at modulating signaling pathways associated with PDLIM5.
One of the significant scientific advantages of using PDLIM5 Gene Knockout Cell Lines is their specificity and resilience, offering researchers a superior alternative to traditional siRNA-mediated knockdown methodologies, which can yield off-target effects and variable silencing efficiency. These knockout lines ensure robust and reproducible experimental conditions, thus enhancing the reliability of research outcomes.
For researchers and clinicians alike, the ability to study PDLIM5 in a controlled, knockout context provides deep insights into its biological and pathological roles. This facilitates the development of novel therapeutic approaches targeting diseases linked to dysregulated PDLIM5 activity.
Our company is dedicated to advancing research through reliable genetic tools, and our PDLIM5 Gene Knockout Cell Lines exemplify our commitment to supporting the scientific community with high-quality, innovative products that drive research forward and enhance understanding of critical cellular mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.